Search results for " Ginecologia"

showing 10 items of 319 documents

HPV genotype prevalence in cytologically abnormal cervical samples from women living in south Italy

2007

Human papillomavirus (HPV) infection is the commonest sexually transmitted infection, and high-risk HPV types are associated with cervical carcinogenesis. This study investigated: the HPV type-specific prevalence in 970 women with an abnormal cytological diagnosis; and the association of HPV infection and cervical disease in a subset of 626 women with a histological diagnosis. HPV-DNA was researched by nested PCR/sequencing and the INNOLiPA HPV Genotyping assay. The data were analysed by the chi-square test (p ? 0.05 significant). Overall, the HPV prevalence was 37.7%; high-risk genotypes were found in 88.5% of women and multiple-type infections in 30.9% of the HPV-positive women. The commo…

AdultHpv genotypesCancer Researchmedicine.medical_specialtyAdolescentGenotypeCervix UteriBiologyPolymerase Chain ReactionVirologyInternal medicineHistological diagnosisGenotypeEpidemiologyPrevalencedistributionmedicineHumanssamplesPapillomaviridaeHigh prevalenceHpv typesPapillomavirus InfectionscervicalHPV infectionvirus diseasesMiddle AgedUterine Cervical Dysplasiamedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaVirologyfemale genital diseases and pregnancy complicationsInfectious DiseasesItalyDNA ViralFemaleNested polymerase chain reactionVirus Research
researchProduct

Laparoscopic sentinel node mapping with intracervical indocyanine green injection for endometrial cancer: the SENTIFAIL study – a multicentric analys…

2020

ObjectivesLaparoscopy is commonly used for endometrial cancer treatment, and sentinel lymph node (SLN) mapping has become the standard procedure for nodal assessment. Despite the standardization of the technique, there is no definitive data regarding its failure rate. The objective of this study is to identify factors associated with unsuccessful SLN mapping in endometrial cancer patients undergoing laparoscopic SLN mapping after intracervical indocyanine green (ICG) injection.MethodsWe retrospectively evaluated a consecutive series of endometrial cancer patients who underwent laparoscopic SLN mapping with intracervical ICG injection, in four oncological referral centers from January 2016 t…

AdultIndocyanine Greenmedicine.medical_specialtyendometrial neoplasmsDatabases Factualmedicine.medical_treatmentSentinel lymph nodeuterine cancerchemistry.chemical_compoundsentinel lymph nodeUterine cancermedicineHumansColoring AgentsLaparoscopyLymph nodeAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testSentinel Lymph Node Biopsybusiness.industryEndometrial cancerObstetrics and GynecologyMiddle AgedSentinel nodemedicine.diseaseuterine neoplasmSettore MED/40 - GINECOLOGIA E OSTETRICIAmedicine.anatomical_structureOncologychemistryLymphatic MetastasisSLN and lympadenectomyFemaleLaparoscopyendometrial neoplasmLymphadenectomyRadiologyuterine neoplasmsbusinessIndocyanine greenInternational Journal of Gynecologic Cancer
researchProduct

Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results

2012

background: Deep infiltrating endometriosis (DIE) is a complex disease that impairs the quality of life and the fertility of women. Since a medical approach is often insufficient, a minimally invasive approach is considered the gold standard for complete disease excision. Roboticassisted surgery is a revolutionary approach, with several advantages compared with traditional laparoscopic surgery. methods: From March 2010 to May 2011, we performed 22 consecutive robotic-assisted complete laparoscopic excisions of DIE endometriosis with colorectal involvement. All clinical data were collected by our team and all patients were interviewed preoperatively and 3 and 6 months post-operatively and ye…

AdultLaparoscopic surgerymedicine.medical_specialtyAdolescentmedicine.medical_treatmentEndometriosisEndometriosisIleostomyPostoperative ComplicationsROBOTIC SURGERYLaparotomymedicineHumansLaparoscopyRetrospective Studiesmedicine.diagnostic_testbusiness.industryRehabilitationColostomyObstetrics and GynecologyRoboticsMiddle AgedDebulkingmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSurgeryRectal DiseasesTreatment OutcomeReproductive MedicineFemaleLaparoscopySegmental resectionbusinessdeep endometriosis / colorectal endometriosis / robotic-assisted laparoscopy
researchProduct

How to select early-stage cervical cancer patients still suitable for laparoscopic radical hysterectomy: a propensity-matched study

2020

Background: Recently, it was reported that minimally invasive surgery (MIS) has a negative impact on early-stage cervical cancer (ECC) patient survival. At the same time, advantages of MIS regarding quality of life and low rate of intra- and postoperative complications are well known. Therefore, it is essential to select patients who may benefit from MIS without worsening their oncologic outcomes. The aim of this study is to investigate which pathological factors could guide surgeons’ choice about the best approach in ECC. Patients and Methods: Patients with 2009 FIGO stage from IA1 with lymphovascular space invasion (LVSI) to IB1/IIA1 treated by open or laparoscopic surgery were judged eli…

AdultLaparoscopic surgerymedicine.medical_specialtymedicine.medical_treatmentlaparoscopyUterine Cervical NeoplasmsHysterectomyDisease-Free Survivalopen surgeryYoung Adult03 medical and health sciences0302 clinical medicineSurgical oncologymedicineHumansMinimally Invasive Surgical ProceduresRadical HysterectomyPropensity ScoreLaparoscopyGrading (tumors)minimally invasive surgeryAgedNeoplasm StagingRetrospective StudiesAged 80 and overCervical cancermedicine.diagnostic_testbusiness.industryParametrialCervical cancer; laparoscopy; minimally invasive surgery; open surgery; radical hysterectomy; tumor diameterHazard ratioMiddle Agedmedicine.diseaseSurgerySurvival RateTreatment OutcomeSettore MED/40 - GINECOLOGIA E OSTETRICIAItalyOncology030220 oncology & carcinogenesisradical hysterectomyCervical cancerFemale030211 gastroenterology & hepatologySurgerytumor diameterbusiness
researchProduct

HPV infection in semen: results from a new molecular approach

2019

AbstractHuman papillomavirus (HPV) is the agent of the most common sexually transmitted diseases causing a variety of clinical manifestations ranging from warts to cancer. Oncogenic HPV infection is the major cause of cervical cancer and less frequently of penile cancers. Its presence in semen is widely known, but the effects on fertility are still controversial. We developed a new approach to evaluate virus localisation in the different semen components. We analysed also the specific genotype localisation and viral DNA quantity by qPCR. Results show that HPV DNA can be identified in every fraction of semen: spermatozoa, somatic cells and seminal plasma. Different samples can contain the HP…

AdultMale0301 basic medicineSettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypesexually transmitted diseasesEpidemiologySemenSettore BIO/11 - Biologia MolecolareBiologyVirusmale infertilityMale infertilityYoung Adult03 medical and health sciences0302 clinical medicineSemenGenotypePrevalencemedicineHumansSettore BIO/06 - Anatomia Comparata E CitologiaPapillomaviridaesemen parametersCervical cancerOriginal Paper030219 obstetrics & reproductive medicinePapillomavirus InfectionsHPV infectionvirus diseasesCancersexually transmitted diseaseMiddle Agedsemen infectionmedicine.diseaseVirologySpermSettore MED/40 - Ginecologia E Ostetricia030104 developmental biologyInfectious DiseasesItalyDNA ViralHPV infectionsemen parameterviral infection
researchProduct

Implication of the Examining Pathologist to Meet the Oncologic Standard of Lymph Node Count after Laparoscopic Lymphadenectomy

2010

<i>Objective:</i> The lymph node number as benchmark in oncologic operations depends on the patient’s anatomy, surgeon’s skill and pathologist’s accuracy. The influence of the pathologist is barely evaluated. <i>Methods:</i> A retrospective analysis of lymph node numbers after 700 laparoscopic lymphadenectomies in correlation to the examining pathologists was done. Three surgeons from the same department performed all operations at 2 campi, where 2 separate pathology institutions exist. Lymph node specimens were assigned randomly to any of the 62 involved pathologists. <i>Results:</i> The mean number of lymph nodes was equal for all surgeons. Lymph node s…

AdultMaleCancer Researchmedicine.medical_specialtyPathologyAdolescentPelviPathology Surgicalmedicine.medical_treatmentGynecologic oncologyMedical OncologyPelvisYoung AdultRetrospective StudieGynecologic oncology; Laparoscopic lymphadenectomy; Lymph node numberNeoplasmsHumansMedicineLaparoscopyLaparoscopic lymphadenectomyLymph nodeAgedNeoplasm StagingRetrospective StudiesAged 80 and overLaparoscopic lymphadenectomymedicine.diagnostic_testbusiness.industryGeneral surgeryLymph NodeGeneral MedicineMiddle AgedSettore MED/40 - Ginecologia E Ostetriciadigestive system diseasesEndoscopyGynecologic oncologysurgical procedures operativemedicine.anatomical_structureOncologyLymph node numberPractice Guidelines as TopicNeoplasmLymph Node ExcisionFemaleLaparoscopyLymphadenectomyLymph NodesbusinessHumanOncology
researchProduct

Prevalence of human papilloma virus infection in patients with male accessory gland infection

2015

The frequency of human papillomavirus (HPV) infection in the semen of patients with male accessory gland infection (MAGI) was evaluated. One hundred infertile patients with MAGI were classified into group A: patients with an inflammatory MAGI (n = 48) and group B: patients with a microbial form (n = 52). Healthy age-matched fertile men (34.0 ± 4.0 years) made up the control group (n = 20). Amplification of HPV DNA was carried out by HPV-HS Bio nested polymerase chain reaction for the detection of HPV DNA sequences within the L1 ORF. Ten patients in group A (20.8%) and 15 patients in group B (28.8%) had a HPV infection; two controls (10.0%) had HPV infection. Patients with MAGI had a signifi…

AdultMaleHPVSemenComorbidityMAGIBiologyGroup AGroup BSemenmedicinePrevalenceHumansPapillomaviridaeInfertility MaleInflammationPapillomavirus InfectionsHPV infectionvirus diseasesObstetrics and GynecologyHPV MAGI Prevalencemedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaSpermfemale genital diseases and pregnancy complicationsProstatitisSemen AnalysisHPV; MAGI; PrevalenceReproductive MedicineMale accessory gland infectionImmunologySperm MotilityGenital Diseases Malemedicine.symptomNested polymerase chain reactionMagiDevelopmental Biology
researchProduct

Hysteroscopic resection of the septum improves the pregnancy rate of women with unexplained infertility: a prospectine controlled trial

2009

Objective: To assess fecundity of infertile women after surgical correction of uterine septum. Design: Prospective controlled trial. Setting: Three academic infertility clinics. Patient(s): Forty-four women affected by septate uterus and otherwise unexplained infertility represented the study group (group A), and 132 women with unexplained infertility were enrolled as control subjects (group B). Intervention(s): Hysteroscopic metroplasty was performed in group A, and group B was managed expectantly. All women were followed-up for 1 year without any other intervention. Main Outcome Measure(s): Fecundity rate was calculated as the number of pregnancies per 100 person-months Result(s): Pregnan…

AdultMaleInfertilitymedicine.medical_specialtyAdolescentPregnancy RateMetroplastyfecunditymedia_common.quotation_subjectseptate uteruFertilityCervix UteriHysteroscopyYoung AdultPregnancySemenmedicineHumansLongitudinal StudiesProspective StudiesHysteroscopic metroplastyBirth RateCerclage CervicalUnexplained infertilitymedia_commonUterine septumUterine DiseasesGynecologyPregnancyprimary infertilitybusiness.industryArcuate uterusObstetricsUterusFemale infertilityInfant NewbornObstetrics and GynecologyBacterial Infectionsmedicine.diseaseSettore MED/40 - Ginecologia E OstetriciaAbortion SpontaneousFertilityReproductive MedicineHisteroscopic metroplasty septate uterus primary infertility fecundityFemalebusinessInfertility FemaleInfant Premature
researchProduct

Detection of oncogenic human papillomavirus genotypes on spermatozoa from male partners of infertile couples

2013

Objective To evaluate the prevalence of human papillomavirus (HPV) sperm infection and its correlation with sperm parameters in patients who attended a fertility clinic. Design Cross-sectional clinical study. Setting University-affiliated reproductive medicine clinic. Patient(s) A total of 308 male partners of couples undergoing in vitro fertilization techniques. Intervention(s) Specimens of semen were collected from all patients. Main Outcome Measure(s) Sperm parameters were evaluated according to the World Health Organization manual. The presence of HPV DNA was researched by the combined use of two HPV assays and a highly sensitive nested polymerase chain reaction assay followed by HPV ge…

AdultMaleendocrine systemmedicine.medical_specialtyGenotypeReproductive medicineSemenFertilization in VitroBiologyPolymerase Chain ReactionHuman Papillomavirus DNA TestsMale infertilityAndrologySemen qualityPredictive Value of TestsRisk FactorsGenotypemedicineHumansPapillomaviridaeIn Situ HybridizationInfertility MaleAcademic Medical CentersSperm Counturogenital systemPapillomavirus InfectionsHPV infectionvirus diseasesObstetrics and Gynecologymedicine.diseaseSpermatozoaSpermSettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsFertilityReproductive MedicineCase-Control StudiesDNA ViralSperm MotilitySperm HeadHPV infection semen parameters IVF ICSINested polymerase chain reaction
researchProduct

Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared wit…

2011

BACKGROUND: The human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine is immunogenic, has a clinically acceptable safety profile, and prevents incident and persistent HPV-16/18 infection and cervical precancerous lesions. This study (NCT00552279) evaluated the vaccine when administered according to an alternative dosing schedule (0-1-12 months) compared with the standard dosing schedule (0-1-6 months). METHODS: The study was of randomized open design and was conducted at multiple centers in Europe. Healthy women aged 15 to 25 years were randomized (1:1) to receive HPV-16/18 vaccine according to the standard schedule at months 0, 1, and 6 (n = 401) or an alternative schedule at months 0, …

AdultMicrobiology (medical)medicine.medical_specialtyScheduleAdolescentImmunization SecondaryEnzyme-Linked Immunosorbent AssayAntibodies Virallaw.inventionYoung AdultAdjuvants ImmunologicRandomized controlled triallawInternal medicinemedicineHumansPapillomavirus VaccinesDosingHuman papillomavirusYoung adultbusiness.industryImmunogenicityhuman papillomavirus human papillomavirus vaccines adolescent immunology alternative dosing scheduleVaccinationvirus diseasesSettore MED/40 - Ginecologia E Ostetriciafemale genital diseases and pregnancy complicationsEuropeSafety profileInfectious DiseasesImmunizationPediatrics Perinatology and Child HealthImmunologyFemalebusiness
researchProduct